Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MiMedx Group Inc.

    NASDAQ: MDXG · Real-Time Price · USD
    5.98
    -0.06 (-0.99%)
    At close: Jun 16, 2025, 3:59 PM
    5.81
    -2.84%
    Pre-market: Jun 17, 2025, 04:14 AM EDT

    MiMedx Statistics

    Share Statistics

    MiMedx has 147.7M shares outstanding. The number of shares has increased by -0.16% in one year.

    Shares Outstanding

    n/a
    		 147.7M

    Shares Change (YoY)

    n/a
    		 -0.16%

    Shares Change (QoQ)

    n/a
    		 0.29%

    Owned by Institutions (%)

    n/a
    		 68.76%

    Shares Floating

    n/a
    		 115.99M

    Failed to Deliver (FTD) Shares

    n/a
    		 16,839

    FTD / Avg. Volume

    n/a
    		 2.59%

    Short Selling Information

    The latest short interest is 5.19M, so 3.52% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.19M

    Short % of Shares Out

    n/a
    		 3.52%

    Short % of Float

    n/a
    		 4.4%

    Short Ratio (days to cover)

    n/a
    		 9.03

    Valuation Ratios

    The PE ratio is 33.33 and the forward PE ratio is 17.76. MiMedx's PEG ratio is -0.84.

    PE Ratio

    n/a
    		 33.33

    Forward PE

    n/a
    		 17.76

    PS Ratio

    n/a
    		 4.05

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 7.32

    P/FCF Ratio

    n/a
    		 21.92

    PEG Ratio

    n/a
    		 -0.84
    Financial Ratio History

    Enterprise Valuation

    MiMedx has an Enterprise Value (EV) of 1.33B.

    EV / Sales

    n/a
    		 3.81

    EV / EBITDA

    n/a
    		 20.65

    EV / EBIT

    n/a
    		 20.07

    EV / FCF

    n/a
    		 20.59

    Financial Position

    The company has a current ratio of 4.21, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 4.21

    Quick Ratio

    n/a
    		 3.69

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 0.29

    Debt / FCF

    n/a
    		 0.29

    Interest Coverage

    n/a
    		 58.51

    Financial Efficiency

    Return on Equity is 21.97% and Return on Invested Capital is 19.67%.

    Return on Equity

    n/a
    		 21.97%

    Return on Assets

    n/a
    		 16.07%

    Return on Invested Capital

    n/a
    		 19.67%

    Revenue Per Employee

    n/a
    		 $416,820.79

    Profits Per Employee

    n/a
    		 $50,679.81

    Employee Count

    n/a
    		 837

    Asset Turnover

    n/a
    		 1.32

    Inventory Turnover

    n/a
    		 2.52

    Taxes

    Income Tax

    n/a
    		 15.3M

    Effective Tax Rate

    n/a
    		 26.7%

    Stock Price Statistics

    The stock price has increased by -12.95% in the last 52 weeks. The beta is 1.8, so MiMedx's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.8

    52-Week Price Change

    n/a
    		 -12.95%

    50-Day Moving Average

    n/a
    		 6.73

    200-Day Moving Average

    n/a
    		 7.51

    Relative Strength Index (RSI)

    n/a
    		 32.68

    Average Volume (20 Days)

    n/a
    		 649,877

    Income Statement

    In the last 12 months, MiMedx had revenue of 348.88M and earned 42.42M in profits. Earnings per share was 0.29.

    Revenue

    n/a
    		 348.88M

    Gross Profit

    n/a
    		 288.81M

    Operating Income

    n/a
    		 58.87M

    Net Income

    n/a
    		 42.42M

    EBITDA

    n/a
    		 64.34M

    EBIT

    n/a
    		 58.3M

    Earnings Per Share (EPS)

    n/a
    		 0.29
    Full Income Statement

    Balance Sheet

    The company has 104.42M in cash and 18.83M in debt, giving a net cash position of 85.59M.

    Cash & Cash Equivalents

    n/a
    		 104.42M

    Total Debt

    n/a
    		 18.83M

    Net Cash

    n/a
    		 85.59M

    Retained Earnings

    n/a
    		 -91.26M

    Total Assets

    n/a
    		 270.42M

    Working Capital

    n/a
    		 157.49M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 66.2M and capital expenditures -1.68M, giving a free cash flow of 64.52M.

    Operating Cash Flow

    n/a
    		 66.2M

    Capital Expenditures

    n/a
    		 -1.68M

    Free Cash Flow

    n/a
    		 64.52M

    FCF Per Share

    n/a
    		 0.44
    Full Cash Flow Statement

    Margins

    Gross margin is 82.78%, with operating and profit margins of 16.87% and 12.16%.

    Gross Margin

    n/a
    		 82.78%

    Operating Margin

    n/a
    		 16.87%

    Pretax Margin

    n/a
    		 16.42%

    Profit Margin

    n/a
    		 12.16%

    EBITDA Margin

    n/a
    		 18.44%

    EBIT Margin

    n/a
    		 16.87%

    FCF Margin

    n/a
    		 18.49%

    Dividends & Yields

    MDXG does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 3%

    FCF Yield

    n/a
    		 4.56%
    Dividend Details

    Analyst Forecast

    The average price target for MDXG is $12.5, which is 109% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12.5

    Price Target Difference

    n/a
    		 109%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 2.92

    Graham Upside

    n/a
    		 -51.17%

    Stock Splits

    The last stock split was on Apr 2, 2008. It was a backward split with a ratio of 647:2000.

    Last Split Date

    n/a
    		 Apr 2, 2008

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 647:2000

    Scores

    Altman Z-Score

    n/a
    		 10.8

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist